Analysts see Trump’s victory raising the high-profile legislation’s chances of becoming law. But the realities of a lame duck ...

Lilly is aiming to strengthen its position as a leader in the obesity treatment market, which is expected to hit $150 billion ...

About 44% of U.S. employers with 500 or more employees cover drugs for weight loss in 2024, up from 41% in 2023, according to ...

Investors are fearful RFK Jr.'s critical stance on weight loss drugs could impact pricing or Medicare coverage, but BMO says ...

Novo Nordisk stock has been pretty volatile lately, making it hard to judge whether now is a good opportunity to buy shares.

Hi, it's Amber in Hong Kong. Blockbuster weight-loss drug Wegovy is going to be much cheaper in China than it is in the US.

The move intensifies the competition with Eli Lilly, which secured approval for its weight loss drug in China in July but has ...

The Bank of England said retailers were right to warn of job cuts UK inflation accelerated sharply back up to 2.3% in October ...

The newspapers are full of colourful accounts of yesterday's protests in which 13,000 farmers took to the streets of ...

Novo Nordisk has launched its weight-loss drug Wegovy in China after it was approved by local health authorities in June. It ...

Healthcare is an active sector for M&A, with deals such as Johnson & Johnson's acquisition of heart device business Shockwave ...

Rafael Nadal said he has left both a sporting and personal legacy after retiring from professional tennis on Tuesday at the ...